Suchergebnisse - "Shi, Youyang"

PubPharm (37)

1

Xianling Lianxia formula enhances the inhibitory effects of trastuzumab on HER2-positive breast cancer

enthalten in: Acta biochimica et biophysica Sinica | 2024

von Li, F. | Wu, Y. | Shi, Y. | +3

2

Integrated network pharmacology and experimental verification to explore the potential mechanism of San Ying decoction for treating triple-negative breast cancer

enthalten in: Acta biochimica et biophysica Sinica | 2024

von Yang, X. | Li, F. | Shi, Y. | +10

3

Investigating the Immunogenic Cell Death-Dependent Subtypes and Prognostic Signature of Triple-Negative Breast Cancer

enthalten in: Phenomics (Cham, Switzerland) | 2024

von Shi, Y. | Wu, Y. | Li, F. | +11

4

Investigating the Immunogenic Cell Death-Dependent Subtypes and Prognostic Signature of Triple-Negative Breast Cancer

enthalten in: Phenomics | 2024

von Shi, Y. | Wu, Y. | Li, F. | +11

5

Xianling Lianxia formula enhances the inhibitory effects of trastuzumab on HER2-positive breast cancer

in: Acta Biochimica et Biophysica Sinica | 2024

von Li Feifei | Wu Yuanyuan | Shi Youyang | +3

6

Xianlinglianxiafang Inhibited the growth and metastasis of triple-negative breast cancer via activating PPARγ/AMPK signaling pathway

enthalten in: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie | 2023

von Yang, X. | Yang, R. | Zhang, Y. | +6

7

Retracted] Celastrus orbiculatus extracts induce apoptosis and inhibit invasion by targeting the maspin gene in human gastric adenocarcinoma cells

enthalten in: Oncology letters | 2023

von Qian, Y. | Lu, S. | Shi, Y. | +4

RetractionOf: Oncol Lett. 2018 Jan;15(1):243-249. - PMID 29387218

8

Traditional Chinese medicine composition for treating triple negative breast cancer as well as preparation method and application of traditional Chinese medicine composition

enthalten in: Europäisches Patentamt | 2023

von LIU SHENG | HAN XIANGHUI | SUN PING | +6

9

Traditional Chinese medicine composition for treating triple negative breast cancer as well as preparation method and application of traditional Chinese medicine composition

enthalten in: Europäisches Patentamt | 2023

von LIU SHENG | HAN XIANGHUI | SUN PING | +6

10

Efficacy and safety of olaparib combined with abiraterone in patients with metastatic castration-resistant prostate cancer : a systematic review and meta-analysis of randomized controlled trials

enthalten in: Frontiers in oncology | 2023

von Luo, Z. | Zhu, B. | Xu, H. | +8